Theophylline induces a reduction in circulating interleukin-4 and interleukin-5 in atopic asthmatics

European Respiratory Journal

Volumn 13, Issue 1, 1999, Pages 53-58

  Kosmas, E N ^a   Michaelides, S A ^a   Polychronaki, A ^a   Roussou, T ^a   Toukmatzi, S ^a   Polychronopoulos, V ^a   Baxevanis, C N ^b  

^a AMALIA FLEMING GENERAL HOSPITAL   (Greece)

^b Immunology Laboratory   (Greece)

Author keywords

Asthma; Cytokines; Interleukin 4; Interleukin 5; Theophylline

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; PHOSPHODIESTERASE INHIBITOR; PLACEBO; THEOPHYLLINE;

ADULT; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; IMMUNOMODULATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SPIROMETRY;

ADULT; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; HUMANS; INTERLEUKIN-4; INTERLEUKIN-5; MALE; THEOPHYLLINE;

EID: 0033039944     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Persson CGA. Overview of effects of theophylllne. J Allergy Clin Immunol 1986; 78: 780-787.
2. Torphy TJ, Undem BJ. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 1991; 46: 512-523.
3. Pauwels RA. The effects of theophylline on airway inflammation. Chest 1987; 92: 32S-37S.
4. Persson CGA. Xanthines as airway antiinflanimatory drugs. J Allergy Clin Immunol 1988; 81: 615-617.
5. Banner KH, Page CP. Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma. Eur Respir J 1995; 8: 996-1000.
6. Holgate ST. Asthma: past, present and future. Ear Respir J 1993; 6: 1507-1520.
7. Humbert M, Durham SR, Ying S. et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996; 154: 1497-1504.
8. Essayan DM, Kage Y, Sobotka A, Lichtenstein LM, Huang SR. Modulation of allergen-induced cytokine gene expression and proliferation by phosphodiesterase inhibitors In vitro. J Allergy Clin Immunol 1993; 91: 254-259.
9. Finnerty JP, Lee C, Wilson S, Madden J, Djukanovic R, Holgate ST. Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group study. Eur Respir J 1996; 9: 1672-1677.
10. Global Initiative for Asthma (GINA). Diagnosis and classification of asthma. NHLBI/WHO Report No. 95-3659, 1995.
11. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997; 10: 646-651.
12. Schwiebert LA, Beck LA, Stellato C, Bickel CA, Bochner BS, Schleimer RP. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J Allergy Clin Immunol 1996; 97: 143-152.
13. Kay AB. "Helper" (CD4+) T-cells and eosinophils in allergy and asthma. Am Rev Respir Dis 1992; 145: S22-S26.
14. Wilson J. Djukanovic WR, Howarth PH, Holgate ST. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. Am Rev Respir Dis 1992; 145: 958-960.
15. Page CP. Theophylline as an anti-inflammatory agent. Eur Respir Rev 1996; 6(34): 74-78.
16. Tang C, Rolland JM, Ward C, Quan B, Walters EH. IL-5 production by bronchoalveolar lavage and peripheral blood mononuclear cells in asthma and atopy. Eur Respir J 1997; 10: 624-632.
17. Wardlavv AJ, Kay AB. The role of the eosinophil in the pathogenesis of asthma. Allergy 1987; 42: 321-335.
18. Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
19. Bradding P, Roberts JA, Britten KM. et al. Interleukin-4, -5, and -6 are tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-480.
20. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for Th2 type (IL-4 and IL-5) and ThI type (IL-2 and IFN-gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatics and normal control subjects. Am J Respir Cell Mol Biol 1995; 12: 477-487.
21. Del Prete GF, Maggi E, Parronehi P, et al. IL-4 is an essential co-factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988; 140: 4193-4198.
22. Robinson DS, Ying S, Bentley AM, et al. Relationships among numbers of bronchoalveolar lavage cells expressing inRNA for cytokines, asthma symptoms and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993; 92: 397-403.
23. Robinson DS, Hamid Q,Ying S, et al. Prednisolone treatment in asthma is associated with modulation of bron choalveolar lavage cell interleukin-4, interleukin-5 and interferon-γ cytokine gene expression. Am Rev Respir Dis 1993; 148: 401-406.
24. Barnes PJ. Cyclic nucleotides and phosphodiesterases and airway function. Eur Respir J 1995; 8: 457-462.
25. Ward AJM, McKenniff M, Evans JM, Page CP, Costello JF. Theophylline: an immunomodulatory role in asthma. Am Rev Respir Dis 1993; 147: 518-523.
26. Barnes PJ, Pauwels RA. Theophylline in asthma: time for reappraisal? Eur Respir J 1994; 7: 579-591.
27. Jaffar ZH, Sullivan P, Page C, Costello J. Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics. Eur Respir J 1996; 9: 456-462.
28. Kidney JC, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ. Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995; 151: 1907-1914.
29. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in asthma. Lancet 1994; 343: 1006-1008.
30. Hatzelmann A, Tenor H, Schudt C. Differential effects of nonselective and selective phosphodiesterase inhibitors on human eosinophil function. Br J Pharmacol 1995; 114: 821-831.
31. Julius P, Warner JA, Häfner D, et al. Modulation of BAL. histamine and ECP concentrations by theophylline in bronchial asthma following endobronchial allergen challenge. Eur Respir J 1995; 8: Suppl. 19, 9s.
32. Lagente V, Pruniaux MP, Junien JL, Moodley I. Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors. Am J Respir Crit Care Med 1995; 151: 1720-1724.
33. Djukanovic R, Finnerty JP, Lee C, Wilson S, Madden J, Holgate ST. The effects of theophylline on mucosal inflammation in asthmatic airways: biopsy results. Eur Respir J 1995; 8: 831-833.
34. Torphy TJ. Phosphodiesterase isozymes: molecular targels for novel antiasthma agents. Am J Respir Crit Care Med 1998; 157: 351-370.